Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DM

David A. Mareska — 24 Patents

ABArray Biopharma: 11 patents #62 of 335Top 20%
KBKnopp Biosciences: 9 patents #4 of 33Top 15%
BTBiohaven Therapeutics: 4 patents #8 of 36Top 25%
AMAmgen: 1 patents #1,873 of 2,867Top 70%
McMurray, PA: #5 of 178 inventorsTop 3%
Pennsylvania: #2,638 of 74,527 inventorsTop 4%
Overall (All Time): #168,038 of 4,157,543Top 5%
24 Patents All Time
David A. Mareska has been granted 24 US patents while listed as an inventor at Array Biopharma. The first was granted in 2006 and the most recent in July 2025. David A. Mareska ranks #168,038 of 4,157,543 US inventors in our database (top 4.0%). Patent records list David A. Mareska in McMurray, PA, US.

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12351559 Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activators Lynn Resnick, George T. Topalov, Justin K. Belardi, James S. Hale, Scott Harried +1 more 2025-07-08
12286408 KV7 channel activators compositions and methods of use Michael E. Bozik, Scott Harried, Lynn Resnick, George T. Topalov, Justin K. Belardi +2 more 2025-04-29
11834418 Benzoimidazol-1,2-yl amides as Kv7 channel activators Lynn Resnick, George T. Topalov, Justin K. Belardi, James S. Hale, Scott Harried +1 more 2023-12-05
11724990 Kv7 channel activators compositions and methods of use Michael E. Bozik, Scott Harried, Lynn Resnick, George T. Topalov, Justin K. Belardi +2 more 2023-08-15
11261162 KV7 channel activators compositions and methods of use Michael E. Bozik, Scott Harried, Lynn Resnick, George T. Topalov, Justin K. Belardi +2 more 2022-03-01
10906877 Benzoimidazol-1,2-yl amides as Kv7 channel activators Lynn Resnick, George T. Topalov, Justin K. Belardi, James S. Hale, Scott Harried +1 more 2021-02-02
10851067 Kv7 channel activators compositions and methods of use Michael E. Bozik, Scott Harried, Lynn Resnick, George T. Topalov, Justin K. Belardi +2 more 2020-12-01
10669269 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, Fredrik P. Marmsater +7 more 2020-06-02
10526328 Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activators Lynn Resnick, George T. Topalov, Charles A. Flentge, James S. Hale, Justin K. Belardi +2 more 2020-01-07
10385025 Benzoimidazol-1,2-yl amides as Kv7 channel activators Lynn Resnick, George T. Topalov, Justin K. Belardi, James S. Hale, Scott Harried +1 more 2019-08-20
10106536 Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators Lynn Resnick, George T. Topalov, Charles A. Flentge, James S. Hale 2018-10-23
9914708 Benzoimidazol-1,2-yl amides as Kv7 channel activators Scott Harried, Lynn Resnick, George T. Topalov, Steven A. Boyd, Justin K. Belardi +3 more 2018-03-13
9809590 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, Fredrik P. Marmsater +7 more 2017-11-07 $14,586,000
9650376 Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators Lynn Resnick, George T. Topalov, Steven A. Boyd, Justin K. Belardi, Charles A. Flentge +8 more 2017-05-16
9481653 Benzoimidazol-1,2-yl amides as Kv7 channel activators Lynn Resnick, George T. Topalov, Steven A. Boyd, Justin K. Belardi, Charles A. Flentge +3 more 2016-11-01
9174981 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, Fredrik P. Marmsater +7 more 2015-11-03 $10,851,000
8809538 Piperidine-containing compounds and use thereof Martha E. Rodriguez, Jeremy Hans, Darren Harvey, Robert D. Groneberg, Michael O'Sullivan 2014-08-19 $6,036,000
8754226 Piperidinyl-substituted lactams as GPR119 modulators Thomas D. Aicher, Josef R. Bencsik, Kevin Ronald Condroski, Jay Bradford Fell, John P. Fischer +5 more 2014-06-17 $6,789,000
8518983 P38 inhibitors and methods of use thereof Mark Munson, Youngboo Kim, Robert D. Gronenberg, James P. Rizzi, Martha E. Rodriguez +5 more 2013-08-27 $8,446,000
8017641 P38 inhibitors and methods of use thereof Mark Munson, Youngboo Kim, Robert D. Gronenberg, James P. Rizzi, Martha E. Rodriguez +5 more 2011-09-13 $1,002,000
7799782 P38 inhibitors and methods of use thereof Mark Munson, Youngboo Kim, Robert D. Gronenberg, James P. Rizzi, Martha E. Rodriguez +5 more 2010-09-21 $2,697,000
7521447 P38 inhibitors and methods of use thereof Mark Munson, Youngboo Kim, Robert D. Groneberg, James P. Rizzi, Martha E. Rodriguez +5 more 2009-04-21 $2,205,000
7425631 Compounds and methods of use Robert D. Groneberg, Benny C. Askew, Jr., Derin D'Amico, James Zhan, Andras Toro +14 more 2008-09-16
7078425 Preparation of phosphatase inhibitors Robert D. Groneberg 2006-07-18 $2,923,000